(Q52929382)

English

Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial.

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

plaque psoriasis

1 reference

based on heuristic

inferred from title

Rodney Sinclair

8

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

2

object named as

Georg Stingl

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

author name string

Wolfram Sterry

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Richard G B Langley

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Hugh Zacharie

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Morad Lahfa

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Alberto Giannetti

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Carlos Ferrándiz

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Jean-Hilaire Saurat

9

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

CLEAR Multinational Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

11

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

947-956

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

Biological therapies in the systemic management of psoriasis: International Consensus Conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

The immunologic basis for the treatment of psoriasis with new biologic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

A systematic review of five systemic treatments for severe psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

Relapse, rebound, and psoriasis adverse events: an advisory group report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.06111.X

21 January 2018

Identifiers

10.1111/J.1610-0387.2006.06111.X

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/17081270

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52929382&oldid=1538383909"